Drug Trial Radar · NCT07546500
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
420
Planned (sponsor's estimate)
Start
Apr 17, 2026
Primary completion
May 31, 2028
Study completion Apr 30, 2030
Sponsor
- Lead sponsor
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, IncIndustry
- Sponsor type
- Industry
- Collaborators
- European Network of Gynaecological Oncological Trial Groups (ENGOT); GOG Foundation
- First posted
- Apr 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, Phase 3 trial designed to evaluate the efficacy and safety of azenosertib compared to Investigator's choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein expression.
Conditions
- Ovarian Cancer
Interventions
Investigator's choice of ChemotherapyDrug
The investigator will select the chemotherapy in accordance with the protocol defined requirements. The possible choices as defined by the protocol: * Paclitaxel * Gemcitabine * Pegylated liposomal doxorubicin (PLD) * Topotecan The selected chemotherapy will be administered intravenously
AzenosertibDrug
Azenosertib 400 mg will be administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression free survival (PFS) per RECIST v1.1 as assessed by InvestigatorTime frame: Up to approximately 24 months from the enrollment of the last subject
Locations
129 sites in 22 countries. Site status is shown where the registry gives one.
Site 0107
Phoenix, Arizona · Not yet recruiting
Site 0110
Antioch, California · Not yet recruiting
Site 0104
Beverly Hills, California · Recruiting
Site 0122
Fountain Valley, California · Recruiting
Site 0115
San Francisco, California · Not yet recruiting
Site 0101
Torrance, California · Recruiting
Site 0116
Orlando, Florida · Recruiting
Site 0123
Baltimore, Maryland · Recruiting
Site 0111
Camden, New Jersey · Not yet recruiting
Site 0108
Columbus, Ohio · Not yet recruiting
Site 0105
Portland, Oregon · Not yet recruiting
Site 0109
Philadelphia, Pennsylvania · Recruiting
Site 0113
Philadelphia, Pennsylvania · Not yet recruiting
Site 0114
Willow Grove, Pennsylvania · Not yet recruiting
Site 0112
Sioux Falls, South Dakota · Not yet recruiting
Site 0117
Fort Worth, Texas · Recruiting
Site 2105
Buenos Aires, Argentina · Not yet recruiting
Site 2101
Córdoba, Argentina · Not yet recruiting
Site 2102
Córdoba, Argentina · Not yet recruiting
Site 2104
Rosario, Argentina · Not yet recruiting
Site 2103
San Miguel de Tucumán, Argentina · Not yet recruiting
Site 1101
Randwick, New South Wales, Australia · Recruiting
Site 1105
Westmead, New South Wales, Australia · Not yet recruiting
Site 1108
Wollongong, New South Wales, Australia · Not yet recruiting
Site 1107
South Brisbane, Queensland, Australia · Not yet recruiting
Site 1102
Adelaide, South Australia, Australia · Recruiting
Site 1103
Nedlands, Western Australia, Australia · Not yet recruiting
Site 1104
Subiaco, Western Australia, Australia · Not yet recruiting
Site 3002
Brussels, Belgium · Recruiting
Site 3003
Edegem, Belgium · Not yet recruiting
Site 3001
Leuven, Belgium · Not yet recruiting
Site 2209
Belo Horizonte, Brazil · Not yet recruiting
Site 2208
Curitiba, Brazil · Not yet recruiting
Site 2207
Goiânia, Brazil · Not yet recruiting
Site 2201
Porto Alegre, Brazil · Not yet recruiting
Site 2203
Porto Alegre, Brazil · Not yet recruiting
Site 2205
Rio de Janeiro, Brazil · Not yet recruiting
Site 2206
Rio de Janeiro, Brazil · Not yet recruiting
Site 2202
São José do Rio Preto, Brazil · Not yet recruiting
Site 2204
São Paulo, Brazil · Not yet recruiting
Showing 40 of 129 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.